Theobid Jr.

   
Google
 
Web NewDrugInformation.com

Theobid Jr.


Drug - Theobid Jr.
The trade name of the product as shown on the labeling.

Dosage - CAPSULE, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Theophylline
Multiple ingredients are in alphabetical order.

Strength - 130MG
The potency of the active ingredient(s), Theophylline. May repeat for multiple part products.

Applicant - WHITBY
The firm name holding legal responsibility for Theobid Jr.. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 087854
The FDA assigned number to Theobid Jr.. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Theobid Jr.. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 20, 1985
The date Theobid Jr. was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Theobid Jr.. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Theobid Jr. is in. Format is RX, OTC, DISCN.

Applicant Full Name - Whitby Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Theobid Jr..

Theobid Jr.